| The epidemiology of multiple sclerosis in Europe M Pugliatti, G Rosati, H Carton, T Riise, J Drulovic, L Vécsei, I Milanov European journal of Neurology 13 (7), 700-722, 2006 | 1002 | 2006 |
| Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders K Sas, H Robotka, J Toldi, L Vécsei Journal of the neurological sciences 257 (1-2), 221-239, 2007 | 644 | 2007 |
| Kynurenines in the CNS: recent advances and new questions L Vécsei, L Szalárdy, F Fülöp, J Toldi Nature reviews Drug discovery 12 (1), 64-82, 2013 | 642 | 2013 |
| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 598 | 2017 |
| EFNS guideline on mild traumatic brain injury: report of an EFNS task force PE Vos, L Battistin, G Birbamer, F Gerstenbrand, A Potapov, T Prevec, ... European journal of neurology 9 (3), 207-219, 2002 | 448 | 2002 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 428 | 2011 |
| The kynurenine system and immunoregulation Y Mándi, L Vécsei Journal of neural transmission 119, 197-209, 2012 | 426 | 2012 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 398 | 2013 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 375 | 2015 |
| Mild traumatic brain injury PE Vos, Y Alekseenko, L Battistin, E Ehler, F Gerstenbrand, DF Muresanu, ... European journal of neurology 19 (2), 191-198, 2012 | 315 | 2012 |
| Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients B Tuka, Z Helyes, A Markovics, T Bagoly, J Szolcsányi, N Szabó, E Tóth, ... Cephalalgia 33 (13), 1085-1095, 2013 | 228 | 2013 |
| Monoamine oxidase B inhibitors in Parkinson's disease L Dezsi, L Vecsei CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 208 | 2017 |
| Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection K Sas, E Szabó, L Vécsei Molecules 23 (1), 191, 2018 | 197 | 2018 |
| Role of kynurenines in the central and peripherial nervous systems H Nemeth, J Toldi, L Vecsei Current neurovascular research 2 (3), 249-260, 2005 | 191 | 2005 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 190 | 2019 |
| Exploring the etiological links behind neurodegenerative diseases: Inflammatory cytokines and bioactive kynurenines M Tanaka, J Toldi, L Vécsei International journal of molecular sciences 21 (7), 2431, 2020 | 186 | 2020 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 186 | 2018 |
| Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway M Tanaka, F Tóth, H Polyák, Á Szabó, Y Mándi, L Vécsei Biomedicines 9 (7), 734, 2021 | 176 | 2021 |
| Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial D Cadavid, M Mellion, R Hupperts, KR Edwards, PA Calabresi, J Drulović, ... The Lancet Neurology 18 (9), 845-856, 2019 | 162 | 2019 |
| Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis A Pardutz, I Krizbai, S Multon, L Vecsei, J Schoenen Neuroreport 11 (14), 3071-3075, 2000 | 159 | 2000 |
Klivenyi PeterUniversity of Szeged在 med.u-szeged.hu 的电子邮件经过验证
